The Study China Programme, managed by The University of Manchester, is currently recruiting 200 students for the Winter 2012/2013 programme! Study China is financed by the UK government to provide a three week student experience of Chinese language, culture and business. This unique opportunity allows you to experience life as a student in this fascinating, diverse country. There are a number of bursaries available to contribute towards your own costs which are airfare and spending money, all other costs are funded by the UK government. The three partnership universities participating in this programme are :
1) Beijing Normal University
2) Fudan University ( Shanghai )
Dates:
Arrive – Sunday 16th December 2012
Depart – Saturday 5th January 2013
3) Shanghai University of Finance and Economics
Dates:
Arrive – Thursday 20th December 2012
Depart – Tuesday 8th January 2012
Eligibility: Open to Undergraduate, Masters (including PhD), Nursing Diploma, Foundation degree and HND students. You must be minimum of 18 years old at commencement of programme and holder of a valid EU/EEA passport.
Deadline: Applications will be processed on a rolling basis, it is anticipated that recruitment for this round will be completed by the end of October 2012 at the latest, so apply ASAP.
Further information & Apply: Visit the Study China website
Read about previous BU students’ experiences on Study China here












Join the 17th Annual Postgraduate Research Conference – Wednesday 3 December 2025
BU Festival of Social Sciences invite at RNLI
MaGPIE Presents at UK Parliament: From Mass Graves to Courtroom
Festival of Social Science: Introducing drowning prevention in Bangladesh
BU PhD student attending HIV conference on scholarship
ECR Funding Open Call: Research Culture & Community Grant – Apply Now
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Horizon Europe 2025 Work Programme pre-Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease